We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $103M invested in ESSA Pharma in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more capital invested
Capital invested by funds: $89.8M → $103M (+$13.6M)
0.48% more ownership
Funds ownership: 75.41% → 75.89% (+0.48%)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
8% less funds holding
Funds holding: 39 → 36 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
83% less call options, than puts
Call options by funds: $27K | Put options by funds: $159K
Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
10
Reduced
10
Closed
4
Calls
$27K
Puts
$159K
Net Calls
-$132K
Net Calls Change
-$121K
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$229K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$168K |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$76.4K |
| 4 |
Two Sigma Advisers
New York
|
-$73.2K |
| 5 |
State Street
Boston,
Massachusetts
|
-$65.9K |
